These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
630 related items for PubMed ID: 19342944
21. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases. Han G, Gilks CB, Leung S, Ewanowich CA, Irving JA, Longacre TA, Soslow RA. Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981 [Abstract] [Full Text] [Related]
22. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. McMeekin DS, Burger RA, Manetta A, DiSaia P, Berman ML. Gynecol Oncol; 1995 Oct; 59(1):81-6. PubMed ID: 7557621 [Abstract] [Full Text] [Related]
23. Stage I ovarian carcinoma: different clinical pathologic patterns. Deligdisch L, Pénault-Llorca F, Schlosshauer P, Altchek A, Peiretti M, Nezhat F. Fertil Steril; 2007 Oct; 88(4):906-10. PubMed ID: 17920404 [Abstract] [Full Text] [Related]
24. Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: report of two cases and a possible new histological subtype. Suzuki A, Shiozawa T, Mori A, Kimura K, Konishi I. Gynecol Oncol; 2006 Jun; 101(3):540-4. PubMed ID: 16483639 [Abstract] [Full Text] [Related]
26. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Silva EG, Young RH. Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544 [Abstract] [Full Text] [Related]
27. [The malignant potential of adenofibroma and cystadenofibroma of the ovary and mesovarium. 118 cases including 13 proliferative and 5 carcinomatous]. Randrianjafisamindrakotroka NS, Gasser B, Philippe E. J Gynecol Obstet Biol Reprod (Paris); 1993 Aug; 22(1):33-8. PubMed ID: 8463564 [Abstract] [Full Text] [Related]
28. Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Köbel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, Gilks CB, Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, Vancouver BC. Int J Gynecol Pathol; 2010 May; 29(3):203-11. PubMed ID: 20407318 [Abstract] [Full Text] [Related]
31. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano' P, Candiani M, Parazzini F, Mangili G. Gynecol Oncol; 2014 Jun; 133(3):480-4. PubMed ID: 24642093 [Abstract] [Full Text] [Related]
32. [Clinical analysis of 25 cases of malignant transformation of endometriosis of the ovary]. Qian J, Shi Y, Chen X. Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):667-9. PubMed ID: 11218895 [Abstract] [Full Text] [Related]
33. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis. Chew S, Tham KF, Ratnam SS. Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094 [Abstract] [Full Text] [Related]
34. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Esheba GE, Pate LL, Longacre TA. Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882 [Abstract] [Full Text] [Related]